• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

278.26 +5.26 (+1.93%)
Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences
September 11, 2026
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
September 08, 2026
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Wall Street Is Now Backing the Clarity Act. Here's the Most Likely Scenario for What Happens Next With Crypto. ↗
August 27, 2026
Even if there's no clarity on the Clarity Act, Coinbase and Circle could still power higher over the next 12 months. 
Via The Motley Fool
Topics Government
News headline image
Here's How Much $100 Invested In Charles River 15 Years Ago Would Be Worth Today ↗
August 25, 2026
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.75% on an annualized basis producing an average annual return of 15.76%. Currently, Charles River has a market... 
Via Benzinga
Charles River Laboratories (NYSE:CRL) Tops Q2 Estimates and Raises Full-Year Outlook ↗
August 05, 2026
Via Chartmill
News headline image
3 Inflated Stocks We Approach with Caution
August 25, 2026
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
Via StockStory
News headline image
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
August 20, 2026
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today ↗
August 14, 2026
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.07% on an annualized basis producing an average annual return of 15.79%. Currently, Charles River has a market... 
Via Benzinga
News headline image
1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges
August 14, 2026
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Organic revenue returned to growth as biopharmaceutical demand strengthened. 
Via The Motley Fool
Topics Earnings
News headline image
5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call
August 12, 2026
Charles River Laboratories’ second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management hi... 
Via StockStory
Topics Artificial Intelligence Earnings Economy
News headline image
Charles River Laboratories International Q2 Earnings Call Highlights ↗
August 06, 2026
Charles River Laboratories International (NYSE:CRL) reported second-quarter results that exceeded its prior outlook, citing improved demand in its Discovery and Safety Assessment, or DSA, business and... 
Via MarketBeat
Topics Earnings
News headline image
CRL Q2 Deep Dive: Strategic Portfolio Moves and Biopharma Demand Fuel Margin Expansion
August 06, 2026
Lab services company Charles River Laboratories (NYSE:CRL) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales fell by 2.7% year on ... 
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index ↗
August 05, 2026
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
August 05, 2026
Via Chartmill
Which S&P500 stocks are gapping on Wednesday? ↗
August 05, 2026
Via Chartmill
Wondering what's happening in today's S&P500 pre-market session? ↗
August 05, 2026
Via Chartmill
News headline image
Charles River Laboratories’s (NYSE:CRL) Q2 CY2026 Sales Top Estimates, Stock Soars
August 05, 2026
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 2.7% year... 
Via StockStory
News headline image
Charles River Laboratories Announces Second-Quarter 2026 Results
August 05, 2026
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Earnings: What To Look For From CRL
August 03, 2026
Lab services company Charles River Laboratories (NYSE:CRL) will be reporting results this Wednesday before the bell. Here’s what to look for. Charles River L... 
Via StockStory
These S&P500 stocks are gapping in today's session ↗
July 28, 2026
Via Chartmill
Which S&P500 stocks are gapping on Thursday? ↗
July 23, 2026
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
July 23, 2026
Via Chartmill
News headline image
3 Profitable Stocks with Warning Signs
July 23, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
3 Healthcare Stocks We Approach with Caution
July 22, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
July 20, 2026
Via Chartmill
News headline image
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call
July 15, 2026
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
July 13, 2026
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Reasons to Avoid CRL and 1 Stock to Buy Instead
July 02, 2026
Charles River Laboratories trades at $225.41 and has moved in lockstep with the market. Its shares have returned 11.4% over the last six months while the S&P... 
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
June 24, 2026
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap